Press release
Microscopic Polyangiitis Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, Genentech, Vifor Pharma, InflaRx GmbH, GlaxoSmithKline, InflaRx GmbH, Hoffmann-La Roche
The latest healthcare forecast report provides an in-depth analysis of Microscopic Polyangiitis, offering comprehensive insights into the Microscopic Polyangiitis revenue trends, prevalence, and treatment landscape. The report delves into key Microscopic Polyangiitis statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Microscopic Polyangiitis therapies. Additionally, we cover the landscape of Microscopic Polyangiitis clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Microscopic Polyangiitis treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Microscopic Polyangiitis space.
To Know in detail about the Microscopic Polyangiitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Microscopic Polyangiitis Market Forecast
https://www.delveinsight.com/sample-request/microscopic-polyangiitis-mpa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Microscopic Polyangiitis Market Report:
• The Microscopic Polyangiitis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In November 2024, A new Phase 3 clinical trial is enrolling children and adolescents with active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), the most common forms of ANCA-associated vasculitis (AAV), to evaluate Tavneos (avacopan) in combination with rituximab or cyclophosphamide. Amgen, the developer of Tavneos, which is approved for treating adults with severe and active GPA or MPA, provided a financial update regarding the trial. The pediatric study (NCT06321601), announced earlier this year, aims to recruit up to 20 patients, aged 6-17, at sites in Indiana, North Carolina, and Ohio. Eligible participants include those with newly diagnosed or relapsed disease, and weighing more than 15 kilograms (approximately 33 pounds).
• In August 2024, Artiva Biotherapeutics, Inc. has initiated treatment for the first patient in an investigator-initiated basket trial (IIT) to evaluate AlloNK® in combination with rituximab in patients with rheumatoid arthritis, pemphigus vulgaris, granulomatosis with polyangiitis/microscopic polyangiitis, and SLE. Conducted by Integral Rheumatology & Immunology Specialists (IRIS), a community rheumatology clinic, the trial highlights the potential of making AlloNK® accessible to patients in both community settings and academic or transplant centers. The study is focused on assessing the safety, tolerability, and clinical activity of AlloNK® (also referred to as AB-101).
• In 2023, the market size for microscopic polyangiitis across the 7MM was estimated to exceed USD 30 million.
• Key Microscopic Polyangiitis Companies: Genentech, Vifor Pharma, InflaRx GmbH, GlaxoSmithKline, InflaRx GmbH, Hoffmann-La Roche, Novartis, and others
• Key Microscopic Polyangiitis Therapies: RITUXAN, TAVNEOS, Vilobelimab (IFX-1, CaCP290), Belimumab, IFX-1, Methylprednisolone, Iptacopan, and others
• The Microscopic Polyangiitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Microscopic Polyangiitis pipeline products will significantly revolutionize the Microscopic Polyangiitis market dynamics.
• In 2023, there were approximately 5,000 incident cases of microscopic polyangiitis across the seven major markets. This number is anticipated to decline during the forecast period, primarily due to population decreases in major contributing countries like Japan and Germany, which are expected to lead to a reduction in incidence rates.
• In the US, males account for the majority of gender-specific incident cases.
• Age-specific data indicates that the highest incidence of microscopic polyangiitis occurs in individuals aged 18 years and older, while those aged 0-17 years are the least affected in the US.
Microscopic Polyangiitis Overview
Microscopic Polyangiitis (MPA) is a rare autoimmune disorder that causes inflammation of small blood vessels (vasculitis), leading to damage in various organs. Commonly affected areas include the kidneys, lungs, skin, and nervous system. Symptoms may include fatigue, weight loss, fever, shortness of breath, skin rashes, and blood in urine. MPA is associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA), which help in diagnosis. If untreated, it can lead to serious complications, such as organ failure. Treatment typically involves immunosuppressive medications like corticosteroids and cyclophosphamide to control inflammation and prevent disease progression.
Get a Free sample for the Microscopic Polyangiitis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Microscopic Polyangiitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Microscopic Polyangiitis Epidemiology Segmentation:
The Microscopic Polyangiitis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Microscopic Polyangiitis
• Prevalent Cases of Microscopic Polyangiitis by severity
• Gender-specific Prevalence of Microscopic Polyangiitis
• Diagnosed Cases of Episodic and Chronic Microscopic Polyangiitis
Download the report to understand which factors are driving Microscopic Polyangiitis epidemiology trends @ Microscopic Polyangiitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/microscopic-polyangiitis-mpa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Microscopic Polyangiitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Microscopic Polyangiitis market or expected to get launched during the study period. The analysis covers Microscopic Polyangiitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Microscopic Polyangiitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Microscopic Polyangiitis Therapies and Key Companies
• RITUXAN: Genentech
• TAVNEOS: Vifor Pharma
• Vilobelimab (IFX-1, CaCP290): InflaRx GmbH
• Belimumab: GlaxoSmithKline
• IFX-1: InflaRx GmbH
• Methylprednisolone: Hoffmann-La Roche
• Iptacopan: Novartis
Discover more about therapies set to grab major Microscopic Polyangiitis market share @ Microscopic Polyangiitis Treatment Landscape
https://www.delveinsight.com/sample-request/microscopic-polyangiitis-mpa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Microscopic Polyangiitis Market Drivers
• Advances in Diagnostic Techniques
• Rising Awareness
• Pipeline Therapies
• Increased Healthcare Access
• Growing Research Efforts
Microscopic Polyangiitis Market Barriers
• Limited Awareness in Low-Income Regions
• High Treatment Costs
• Side Effects of Therapies
• Rarity of Disease
• Regulatory Challenges
Scope of the Microscopic Polyangiitis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Microscopic Polyangiitis Companies: Genentech, Vifor Pharma, InflaRx GmbH, GlaxoSmithKline, InflaRx GmbH, Hoffmann-La Roche, Novartis, and others
• Key Microscopic Polyangiitis Therapies: RITUXAN, TAVNEOS, Vilobelimab (IFX-1, CaCP290), Belimumab, IFX-1, Methylprednisolone, Iptacopan, and others
• Microscopic Polyangiitis Therapeutic Assessment: Microscopic Polyangiitis current marketed and Microscopic Polyangiitis emerging therapies
• Microscopic Polyangiitis Market Dynamics: Microscopic Polyangiitis market drivers and Microscopic Polyangiitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Microscopic Polyangiitis Unmet Needs, KOL's views, Analyst's views, Microscopic Polyangiitis Market Access and Reimbursement
To know more about Microscopic Polyangiitis companies working in the treatment market, visit @ Microscopic Polyangiitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/microscopic-polyangiitis-mpa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Microscopic Polyangiitis Market Report Introduction
2. Executive Summary for Microscopic Polyangiitis
3. SWOT analysis of Microscopic Polyangiitis
4. Microscopic Polyangiitis Patient Share (%) Overview at a Glance
5. Microscopic Polyangiitis Market Overview at a Glance
6. Microscopic Polyangiitis Disease Background and Overview
7. Microscopic Polyangiitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Microscopic Polyangiitis
9. Microscopic Polyangiitis Current Treatment and Medical Practices
10. Microscopic Polyangiitis Unmet Needs
11. Microscopic Polyangiitis Emerging Therapies
12. Microscopic Polyangiitis Market Outlook
13. Country-Wise Microscopic Polyangiitis Market Analysis (2020-2034)
14. Microscopic Polyangiitis Market Access and Reimbursement of Therapies
15. Microscopic Polyangiitis Market Drivers
16. Microscopic Polyangiitis Market Barriers
17. Microscopic Polyangiitis Appendix
18. Microscopic Polyangiitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Microscopic Polyangiitis Epidemiology https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Microscopic Polyangiitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Microscopic Polyangiitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
• Nosocomial Infections Market: https://www.delveinsight.com/report-store/nosocomial-infections-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Dry Eye Disease Market: https://www.delveinsight.com/report-store/dry-eye-disease-market-insights
• Nonalcoholic Steatohepatitis Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Female Infertility Market: https://www.delveinsight.com/report-store/female-infertility-market
• Gonorrhea Market: https://www.delveinsight.com/report-store/gonorrhea-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microscopic Polyangiitis Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, Genentech, Vifor Pharma, InflaRx GmbH, GlaxoSmithKline, InflaRx GmbH, Hoffmann-La Roche here
News-ID: 3830659 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Microscopic
Carbon Nanotubes: Super Fibers from the Microscopic World
There is a material that is hundreds of times stronger than steel, more conductive than copper wires, but lighter than to float in mid-air-this is the carbon nanotube (CNT), labeled as the "miracle material of the 21st century." Measured only in thickness, narrower than one ten-thousandth of a human hair, it possesses unprecedented promise to revolutionize sectors such as energy, medicine, and aerospace.
There is a material that is hundreds of…
Microscopic Polyangiitis Treatment Market Gains Ground With New Therapeutic Deve …
Microscopic Polyangiitis Market Overview
The Microscopic Polyangiitis Market is anticipated to grow from USD 0.76 billion in 2025 to USD 1.2 billion by 2032, at a CAGR of 6.8% during the forecast period (2025 - 2032).
The latest report (2025-2032) on the Microscopic Polyangiitis Market by Coherent Market Insights offers an in-depth analysis of evolving trends, key drivers, regulatory updates, and competitive intelligence. It provides data on market size, revenue, therapeutic adoption,…
Therapeutic Products From Microbes: Nature's Microscopic Pharmacy
In the ever-evolving landscape of healthcare and pharmaceutical innovation, a microscopic revolution is quietly transforming how we treat diseases. The microbial world-bacteria, fungi, and other tiny organisms-has emerged as one of the most promising frontiers for developing next-generation therapeutic products. These microscopic powerhouses are no longer viewed merely as threats to human health but as sophisticated biochemical factories capable of producing compounds with remarkable healing properties.
Get a free sample report:…
Microscopic Ring Launched: Smaller Than a Strand of Hair
Image: https://www.abnewswire.com/uploads/aa1ac75dc4cc196ccdbd3905ff99208b.jpg
The science fiction-inspired accessory brand "EPOCH-X" announced the launch of its microscopic ring [https://epoch-x.com/en-ww/pages/microscopic], which is about 25x25x5 micrometers in size, making it around 38,000 times smaller than the $67,350 minuscule purse that MSCHF sold last year.
Image: https://www.abnewswire.com/uploads/cd2172c06d732f7fc8af67d15ccbaaec.jpg
To highlight its tiny and endearing size, this brand-new creation, which is visible under a microscope and smaller than a hair strand, is presented next to a cat. This microscopic ring has…
Nanofibers Market 2023-2029: Microscopic Marvels Shaping Industries
Changing Sectors: Diverse Applications and Technological Advancements Will Drive Global Nanofiber Market to Astonishing $5515 Mn by 2029
The Global Nanofibers Market is poised for unprecedented growth, projected to soar from USD 1098 Mn in 2022 to a remarkable USD 5515 Mn by 2029, at an impressive CAGR of 25.92%. The market's ascent is attributed to the adoption of electro-spinning production methods, offering simplicity, efficiency, and cost-effectiveness. This rise is bolstered…
Electron Microscope Market: Advancements and Innovations Transforming Microscopi …
In 2021, the global electron microscopy market attained a value of $3.7 billion, and it is anticipated to achieve $8.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5% between 2023 and 2030. Electron microscopy, a methodology utilized for obtaining high-resolution images of both biological and non-biological specimens, holds a pivotal role in biomedical research. It furnishes in-depth structural insights into tissues, cells, organelles, and macromolecular complexes.…
